MARKET

LGND

LGND

Ligand Pharma
NASDAQ
319.55
+7.54
+2.42%
After Hours: 319.82 +0.27 +0.08% 17:51 07/02 EDT
OPEN
314.81
PREV CLOSE
312.01
HIGH
320.00
LOW
308.76
VOLUME
368.16K
TURNOVER
--
52 WEEK HIGH
320.99
52 WEEK LOW
111.72
MARKET CAP
6.40B
P/E (TTM)
43.04
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)
TipRanks · 3d ago
Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator
Seeking Alpha · 4d ago
Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust
Seeking Alpha · 4d ago
Weekly Report: what happened at LGND last week (0622-0626)?
Weekly Report · 5d ago
Ligand Pharma Completes Major Convertible Notes Financing Transaction
TipRanks · 06/25 21:35
LIGAND ANNOUNCES CLOSING OF CONVERTIBLE SENIOR NOTES OFFERING
Reuters · 06/25 20:01
Press Release: Ligand Announces Closing of Convertible Senior Notes Offering
Dow Jones · 06/25 20:01
10 mid-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 06/24 13:45
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.